Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,624.73 +698.76 (+1.04%) CMC Crypto 200
1,424.13 -4.44 (-0.31%)
TXG Dec 2024 65.000 call
| Previous close | 2.5000 |
| Open | 2.5000 |
| Bid | 0.1000 |
| Ask | 4.3000 |
| Strike | 65.00 |
| Expiry date | 2024-12-20 |
| Day's range | 2.5000 - 2.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
PR Newswire10x Genomics Launches 5,000-Plex Gene Panel for Xenium
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of its Xenium Prime 5K Pan-Tissue and Pathways panel. The new assay features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation, and industry-leading speed and throughput.
ZacksInternational Markets and 10x Genomics (TXG): A Deep Dive for Investors
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
- PR Newswire
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.
